Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

70
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
70
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

16.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.4K
Genetic Screens02:46

Genetic Screens

5.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review and meta-analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life.

Epilepsia·2026
Same author

An epilepsy-associated KV3.1 potassium channel variant acts via dominant-positive effect.

The Journal of general physiology·2026
Same author

Protein-enhanced small molecule disruptors of ordered membrane domains.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

PGS Browser: a public platform for personalized polygenic score analysis and interpretation.

Nature communications·2026
Same author

Genetic architecture of 67 oral diseases and their links to systemic diseases.

HGG advances·2026
Same author

Cognitive and behavioral clinical outcome assessments in children with developmental and epileptic encephalopathies: Issues and instruments.

Epilepsia·2026

Related Experiment Video

Updated: Mar 14, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.6K

Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant

Tobias Brünger1,2, Ilona Krey3, Suyeon Kim1

  • 1Department of Neurology, The University of Texas Health Science Center at Houston, Houston, TX, USA.

Medrxiv : the Preprint Server for Health Sciences
|March 13, 2026
PubMed
Summary
This summary is machine-generated.

Gene Portals centralize rare disease genetic data, standardizing variant interpretation. This framework integrates diverse evidence to automate classification and discover molecular mechanisms for Mendelian disorders.

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.4K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K

Related Experiment Videos

Last Updated: Mar 14, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
09:37

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

10.6K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.4K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K

Area of Science:

  • Genetics
  • Bioinformatics
  • Medical Genetics

Background:

  • Rare Mendelian disorders impact millions globally, necessitating precise genetic variant interpretation.
  • Current genetic testing faces challenges due to scattered, gene-specific evidence for variant analysis.

Purpose of the Study:

  • To develop Gene Portals, a framework for gene-centered knowledge bases to unify multimodal evidence for rare disease variant interpretation.
  • To enable automated variant classification, infer molecular mechanisms, and support cross-gene analyses.

Main Methods:

  • Created a framework for gene-centered multimodal knowledge bases integrating clinical data, functional assays, population variation, and ACMG/AMP specifications.
  • Developed a modular interface to combine unified evidence with VCEP-refined ACMG specifications for automated classification.
  • Demonstrated utility across five Gene Portals for eleven neurodevelopmental disorder-associated genes.

Main Results:

  • Integrated data from 4,423 individuals, 2,838 variants, 36,149 ClinVar submissions, and 1,044 molecular readouts.
  • The SCN, GRIN, CACNA1A, SATB2, and SLC6A1 Gene Portals became widely used community resources.
  • The framework facilitates standardized rare-disease variant interpretation and mechanism-aware discovery.

Conclusions:

  • Gene Portals provide a unified, queryable resource for dispersed genetic evidence, significantly improving rare disease variant interpretation.
  • The framework offers an extensible template for standardized analysis and discovery in rare genetic disorders.
  • This approach supports community-driven research and clinical application of genetic findings.